Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1738994

Cover Image

PUBLISHER: Bizwit Research & Consulting LLP | PRODUCT CODE: 1738994

Global Excipients Market Size study, by Product (Polymers, Alcohols, Sugars, Minerals, Gelatin), by Formulation (Oral, Topical), by Function (Binders, Coating Agents), and Regional Forecasts 2022-2032

PUBLISHED:
PAGES: 285 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
Unprintable PDF (Single User License)
USD 4950
Printable PDF (Enterprise License)
USD 6250

Add to Cart

Global Excipients Market is valued at approximately USD 9.89 billion in 2023 and is projected to grow at a CAGR of 4.03% over the forecast period 2024-2032. Excipients-substances formulated alongside the active ingredients in pharmaceuticals-play a pivotal role in ensuring drug stability, bioavailability, and controlled release. As pharmaceutical innovation surges forward, the demand for novel excipients that can support new drug formulations has grown tremendously. These often-overlooked components are essential in enhancing solubility, ensuring consistency in drug delivery, and prolonging shelf life. With the expansion of both generic and specialty drugs, the excipients market is rapidly adapting to the demands of advanced therapeutics and customized treatment protocols, reinforcing its foundational role in modern drug development.

The market growth is underpinned by the evolving pharmaceutical landscape, where oral solid dosage forms continue to dominate, yet more sophisticated formulations-like modified-release systems and biologics-are driving demand for more specialized excipient solutions. Functional innovations in excipients, such as co-processed excipients or multifunctional polymers, are enabling better compressibility, improved taste masking, and enhanced drug stability. Regulatory encouragement for patient-centric formulations and the increasing use of biopharmaceuticals further stimulate the need for high-performance excipients. However, challenges remain, particularly surrounding the regulatory approval of novel excipients and the risk associated with their limited toxicological history. These hurdles can impede their adoption in mainstream pharmaceutical manufacturing, especially in cost-sensitive markets.

From the standpoint of product categories, polymers continue to dominate the excipients market owing to their extensive application in controlled and sustained-release drug formulations. Gelatin and alcohol-based excipients are also widely adopted due to their solubilizing and binding properties. Among formulations, the oral segment leads due to its ease of administration, patient compliance, and cost-effectiveness. Meanwhile, the topical formulation segment is growing steadily, driven by rising demand in dermatological and cosmetic applications. Functionally, binders hold the lion's share of the market, closely followed by coating agents which help improve drug stability and provide masking of unpleasant tastes and odors.

Geographically, North America commands the largest share of the global excipients market, bolstered by the region's robust pharmaceutical infrastructure, consistent regulatory oversight, and substantial R&D investments. The United States continues to spearhead innovation in formulation technologies and maintains a large base of pharmaceutical manufacturing. Europe follows closely, benefiting from well-established manufacturing hubs in countries like Germany, Switzerland, and the UK. The Asia Pacific region is anticipated to witness the fastest growth, driven by expanding generic drug production, rising healthcare expenditure, and increasing government support in India, China, and South Korea. Latin America and the Middle East & Africa are also poised for steady growth as pharmaceutical industries in these regions mature and global players expand their footprint.

Major market player included in this report are:

  • BASF SE
  • DuPont de Nemours, Inc.
  • Evonik Industries AG
  • Ashland Global Holdings Inc.
  • Roquette Freres
  • Croda International Plc
  • Associated British Foods plc
  • The Dow Chemical Company
  • Lubrizol Corporation
  • Kerry Group plc
  • Archer Daniels Midland Company
  • Merck KGaA
  • Colorcon Inc.
  • Wacker Chemie AG
  • JRS Pharma GmbH & Co. KG

The detailed segments and sub-segment of the market are explained below:

By Product

  • Polymers
  • Alcohols
  • Sugars
  • Minerals
  • Gelatin

By Formulation

  • Oral
  • Topical

By Function

  • Binders
  • Coating Agents

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market.

Table of Contents

Chapter 1. Global Excipients Market Executive Summary

  • 1.1. Global Excipients Market Size & Forecast (2022-2032)
  • 1.2. Regional Summary
  • 1.3. Segmental Summary
    • 1.3.1. By Product
    • 1.3.2. By Formulation
    • 1.3.3. By Function
  • 1.4. Key Trends
  • 1.5. Recession Impact
  • 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global Excipients Market Definition and Research Assumptions

  • 2.1. Research Objective
  • 2.2. Market Definition
  • 2.3. Research Assumptions
    • 2.3.1. Inclusion & Exclusion
    • 2.3.2. Limitations
    • 2.3.3. Supply Side Analysis
      • 2.3.3.1. Availability
      • 2.3.3.2. Infrastructure
      • 2.3.3.3. Regulatory Environment
      • 2.3.3.4. Market Competition
      • 2.3.3.5. Economic Viability (Consumer's Perspective)
    • 2.3.4. Demand Side Analysis
      • 2.3.4.1. Regulatory Frameworks
      • 2.3.4.2. Technological Advancements
      • 2.3.4.3. Environmental Considerations
      • 2.3.4.4. Consumer Awareness & Acceptance
  • 2.4. Estimation Methodology
  • 2.5. Years Considered for the Study
  • 2.6. Currency Conversion Rates

Chapter 3. Global Excipients Market Dynamics

  • 3.1. Market Drivers
    • 3.1.1. Rising Demand for Advanced Oral and Topical Formulations
    • 3.1.2. Surge in Generic and Specialty Drug Production
    • 3.1.3. Emphasis on Patient-Centric, Controlled-Release Technologies
  • 3.2. Market Challenges
    • 3.2.1. Stringent Regulatory Approval for Novel Excipients
    • 3.2.2. Limited Toxicological and Safety Data
    • 3.2.3. Cost Sensitivity in Emerging Pharma Markets
  • 3.3. Market Opportunities
    • 3.3.1. Development of Co-Processed and Multifunctional Excipients
    • 3.3.2. Expansion in Asia Pacific and Latin American Manufacturing Hubs
    • 3.3.3. Innovation in Bio-derived and Sustainable Excipient Sources

Chapter 4. Global Excipients Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top Investment Opportunity
  • 4.4. Top Winning Strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Excipients Market Size & Forecasts by Product 2022-2032

  • 5.1. Segment Dashboard
  • 5.2. Global Excipients Market: Product Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 5.2.1. Polymers
    • 5.2.2. Alcohols
    • 5.2.3. Sugars
    • 5.2.4. Minerals
    • 5.2.5. Gelatin

Chapter 6. Global Excipients Market Size & Forecasts by Formulation 2022-2032

  • 6.1. Segment Dashboard
  • 6.2. Global Excipients Market: Formulation Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
    • 6.2.1. Oral
    • 6.2.2. Topical

Chapter 7. Global Excipients Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Excipients Market
    • 7.1.1. U.S. Excipients Market
      • 7.1.1.1. Product breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Formulation breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Excipients Market
  • 7.2. Europe Excipients Market
    • 7.2.1. UK Excipients Market
    • 7.2.2. Germany Excipients Market
    • 7.2.3. France Excipients Market
    • 7.2.4. Spain Excipients Market
    • 7.2.5. Italy Excipients Market
    • 7.2.6. Rest of Europe Excipients Market
  • 7.3. Asia-Pacific Excipients Market
    • 7.3.1. China Excipients Market
    • 7.3.2. India Excipients Market
    • 7.3.3. Japan Excipients Market
    • 7.3.4. Australia Excipients Market
    • 7.3.5. South Korea Excipients Market
    • 7.3.6. Rest of Asia Pacific Excipients Market
  • 7.4. Latin America Excipients Market
    • 7.4.1. Brazil Excipients Market
    • 7.4.2. Mexico Excipients Market
    • 7.4.3. Rest of Latin America Excipients Market
  • 7.5. Middle East & Africa Excipients Market
    • 7.5.1. Saudi Arabia Excipients Market
    • 7.5.2. South Africa Excipients Market
    • 7.5.3. Rest of Middle East & Africa Excipients Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
    • 8.1.1. BASF SE
    • 8.1.2. DuPont de Nemours, Inc.
    • 8.1.3. Evonik Industries AG
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. BASF SE
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. DuPont de Nemours, Inc.
    • 8.3.3. Evonik Industries AG
    • 8.3.4. Ashland Global Holdings Inc.
    • 8.3.5. Roquette Freres
    • 8.3.6. Croda International Plc
    • 8.3.7. Associated British Foods plc
    • 8.3.8. The Dow Chemical Company
    • 8.3.9. Lubrizol Corporation
    • 8.3.10. Kerry Group plc
    • 8.3.11. Archer Daniels Midland Company
    • 8.3.12. Merck KGaA
    • 8.3.13. Colorcon Inc.
    • 8.3.14. Wacker Chemie AG
    • 8.3.15. JRS Pharma GmbH & Co. KG

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!